Codon changes challenge PCR-based gene doping detection

Area of Science:

• Sports science
• Molecular biology
• Biotechnology

Background:

• Gene doping, the non-therapeutic use of genes, is a growing concern in sports.
• The World Anti-Doping Agency (WADA) prohibits gene doping and recommends quantitative real-time PCR (qPCR) for detection.
• Current qPCR methods face limitations in detecting novel doping targets and are susceptible to alterations like codon changes.

Purpose of the Study:

• To investigate the impact of codon changes on the detection efficiency of gene doping using qPCR.
• To develop and validate standard materials for detecting genomic and transgenic human EPO (hEPO) gene doping.
• To compare the efficacy of qPCR and Sanger sequencing in identifying gene doping, including codon-modified variants.

Main Methods:

• Preparation of standard materials for genomic and transgenic hEPO genes.
• Design and application of qPCR primers to assess detection of codon-changed transgenes.
• Mimicking real-world gene doping scenarios by mixing wild-type and modified hEPO gene versions.
• Method validation using Sanger sequencing to confirm gene doping detection.

Main Results:

• Carefully designed qPCR assays can detect transgene signals, but codon changes significantly reduce detection efficiency.
• qPCR successfully detected wild-type hEPO but failed to detect codon-changed transgenes in simulated doping scenarios.
• Sanger sequencing effectively identified gene doping, even in the presence of codon changes.
• Codon modifications pose a substantial challenge to current qPCR-based gene doping detection strategies.

Conclusions:

• Codon changes in transgenes present a significant hurdle for qPCR-based gene doping detection.
• The findings highlight the limitations of qPCR in the face of evolving gene doping techniques.
• There is a critical need for the development and implementation of unbiased, high-throughput sequencing methods for comprehensive gene doping surveillance.